259 related articles for article (PubMed ID: 2138669)
41. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
[TBL] [Abstract][Full Text] [Related]
42. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
Neisewander JL; Lucki I; McGonigle P
Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
[TBL] [Abstract][Full Text] [Related]
43. Dopamine D1 receptor development depends on endogenous dopamine.
Gelbard HA; Teicher MH; Baldessarini RJ; Gallitano A; Marsh ER; Zorc J; Faedda G
Brain Res Dev Brain Res; 1990 Oct; 56(1):137-40. PubMed ID: 2149085
[TBL] [Abstract][Full Text] [Related]
44. The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
Rattan AK; Koo KL; Tejwani GA; Bhargava HN
Brain Res; 1992 Jul; 584(1-2):207-12. PubMed ID: 1355391
[TBL] [Abstract][Full Text] [Related]
45. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
Gredal O; Nielsen M
J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877
[TBL] [Abstract][Full Text] [Related]
46. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
Gredal O; Nielsen M; Hyttel J
Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
[TBL] [Abstract][Full Text] [Related]
47. Differential binding of [3H]MK-801 to brain regions and spinal cord of mice treated chronically with morphine.
Gudehithlu KP; Bhargava HN
Gen Pharmacol; 1996 Jan; 27(1):91-4. PubMed ID: 8742501
[TBL] [Abstract][Full Text] [Related]
48. The effect of perinatal lead exposure on dopamine receptor D2 expression in morphine dependent rats.
Listos J; Baranowska-Bosiacka I; Talarek S; Listos P; Orzelska J; Fidecka S; Gutowska I; Kolasa A; Rybicka M; Chlubek D
Toxicology; 2013 Aug; 310():73-83. PubMed ID: 23702354
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of morphine tolerance and dependence by diazepam and its relation to cyclic AMP levels in discrete rat brain regions and spinal cord.
Sheu MJ; Sribanditmongkol P; Santosa DN; Tejwani GA
Brain Res; 1995 Mar; 675(1-2):31-7. PubMed ID: 7796144
[TBL] [Abstract][Full Text] [Related]
50. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
[TBL] [Abstract][Full Text] [Related]
51. Effect of nialamide and reserpine on brain free amino acids of rat dependent on and withdrawn from morphine.
Koyuncuoglu H; Güngör M
Arzneimittelforschung; 1975 Nov; 25(11):1762-6. PubMed ID: 1243083
[TBL] [Abstract][Full Text] [Related]
52. Glucuronidation of the dopamine D-1 receptor antagonists NNC 0756 and NNC 0772 in liver microsomes.
Hansen KT; Thomsen KF; Bundgaard H
Drug Metab Dispos; 1992; 20(2):172-8. PubMed ID: 1352206
[TBL] [Abstract][Full Text] [Related]
53. Beta-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats.
Gudehithlu KP; Tejwani GA; Bhargava HN
Brain Res; 1991 Jul; 553(2):284-90. PubMed ID: 1933285
[TBL] [Abstract][Full Text] [Related]
54. Reduction of [3H]nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors.
Fuxe K; von Euler G; Finnman UB; Agnati LF
Acta Physiol Scand; 1989 Jun; 136(2):295-6. PubMed ID: 2528887
[No Abstract] [Full Text] [Related]
55. The binding of 3H-quinuclidinyl benzilate to cholinergic muscarinic receptors in rat brain region following chronic treatment with morphine and during abstinence.
Das S; Matwyshyn GA; Bhargava HN
Neuropeptides; 1984 Dec; 5(1-3):45-8. PubMed ID: 6543385
[TBL] [Abstract][Full Text] [Related]
56. Regulation of dopamine D1 receptors by chronic administration of structurally different D1 receptor antagonists: a quantitative autoradiographic study.
Lappalainen J; Hietala J; Pohjalainen T; Syvälahti E
Eur J Pharmacol; 1992 Jan; 210(2):195-200. PubMed ID: 1534766
[TBL] [Abstract][Full Text] [Related]
57. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
Zhang X; Segawa T
Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
[TBL] [Abstract][Full Text] [Related]
58. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
De Keyser J; Walraevens H; Ebinger G; Vauquelin G
J Neurochem; 1989 Oct; 53(4):1096-102. PubMed ID: 2527968
[TBL] [Abstract][Full Text] [Related]
59. [MEK inhibitors suppressed expression of NOS in spinal cord of morphine-induced dependent and withdrawal rats].
Liu HL; Li XC; Qiang YN
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):343-7. PubMed ID: 22097732
[TBL] [Abstract][Full Text] [Related]
60. Rats sensitized to morphine are resistant to the behavioral effects of an unavoidable stress.
Scheggi S; Masi F; Tagliamonte A; Gambarana C; Tolu P; De Montis MG
Brain Res; 2000 Jan; 853(2):290-8. PubMed ID: 10640626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
